All News

Domvanalimab plus zimberelimab with chemotherapy demonstrated a positive overall response rate and 6-month progression free survival rate for patients with upper gastrointestinal cancers.

More individuals with systemic lupus erythematosus treated with anifrolumab-fnia reached remission compared to the placebo.

Perfluorohexyloctane is the first and only treatment that targets tear evaporation to provide relief for dry eye disease

Preventative drug lists were associated with a modest increase in adherence to combination inhaled corticosteroid long-acting β2-agonists.

Pharmacists should consult state boards of pharmacy and local, state, or national associations to understand how regulations apply to them

Dr. Christina Madison, speaks with Dr. Jade Ranger, from the Prescription Shoppe in this episode of Public Health matters.

Data show patients are willing to accept associated risks for a chance at a cure.

Tirzepatide is already approved under the brand name Mounjaro (Lilly) to be used along with diet and exercise to improve blood sugar in adults with type 2 diabetes.

CD4+ tissue-resident memory T cells may trigger severe, and potentially fatal, asthma attacks in men aged 40 years and older.

With the organism’s potential to cause severe symptoms, severe disease, and possible death, it is essential to care for infected individuals promptly and safely.

It's key for clinicians to optimize therapy prior to systemic agents.

More individuals who used e-cigarettes have reported pulmonary diseases compared with those who never smoked, including asthma.

Regular usage of cannabis may increase the risk of heart failure, stroke, or heart attack, even after adjusting for other cardiovascular disease risk factors.

TAK-279 is an investigational oral allosteric tyrosine kinase 2 inhibitor for active psoriatic arthritis.

These facilities provide significant value to payers and patients.

AI may help to significantly speed up drug discovery and development, and help researchers end the treatment-resistant infection crisis before it’s too late.

Pricing is also a key issue, as many insurance plans do not cover these medications’ use for obesity.

More studies are needed to show conclusive benefits on patient functionality.

With precision medicine, patients undergoing treatment are living longer without disease recurrence or progression and with fewer adverse effects, resulting in preservation of quality of life.

With the rest of the retail world catching up with pharmacy queuing, will it change customer expectations at the counter?

With appointment-based models in community pharmacy, researchers have noted that community pharmacies are well suited for identifying and addressing social determinants of health.

Infants younger than 6 months old are the highest risk for severe RSV infection, so researchers aim to target this group for prevention methods

Investigators found that there was no association of dementia incidence in insulin use at 5 years after stopping metformin and an association at 0.07 years for HbA1C level at year 1.

In May 2023, the FDA approved brexpiprazole as the first and only drug to receive approval for treatment of agitation associated with Alzheimer Disease dementia.

AI is expected to significantly quicken the pace of drug design and development, while improving the success rate of new medicines.

This comprehensive approach is what all stakeholders, especially patients and families, need and deserve from their health care system.

The need for additional data on safety and efficacy of medicines both new and old that assess all potential risk factors is ever present, with health system pharmacists at the front lines.

A low carbohydrate diet plus a sodium glucose contransporter-2 (SGLT2) inhibitor was found to be safe and effective for weight loss and glycemic control in patients with diabetes and chronic kidney disease.